Chimovits Erez 4
4 · LogicBio Therapeutics, Inc. · Filed Jun 23, 2020
Insider Transaction Report
Form 4
Chimovits Erez
Director
Transactions
- Award
Restricted Stock Units
2020-06-19+2,513→ 2,513 total→ Common Stock (2,513 underlying) - Award
Stock Option (right to buy)
2020-06-19+10,000→ 10,000 totalExercise: $7.96Exp: 2030-06-19→ Common Stock (10,000 underlying)
Footnotes (3)
- [F1]All of the options will vest and become exercisable on the earlier of (i) the one-year anniversary of the date of grant and (ii) the day immediately preceding the date of LogicBio Therapeutics, Inc. (the "Company") 2021 Annual Meeting of Stockholders, subject to the terms and conditions of the award and the Company's 2018 Equity Incentive Plan (the "2018 Plan").
- [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Company's common stock.
- [F3]All of the RSUs will vest on January 1, 2021, subject to the terms and conditions of the award and the Company's 2018 Plan.